| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:457969707:1749 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:457969707:1749?format=raw |
LEADER: 01749cam a2200421 a 4500
001 3913081
005 20221027000631.0
008 841008s1984 sz a b 101 0 eng
010 $a 84011072
020 $a3764316322
035 $a(OCoLC)10777385
035 $a(OCoLC)ocm10777385
035 $a(CStRLIN)NYCM84-B2836
035 $9ADG5369HS
035 $a(NNC)3913081
035 $a3913081
040 $dCStRLIN$dNNC-M
050 00 $aRC694.3$b.T53 1984
082 0 $a616.1/35061$219
245 00 $aTiclopidine :$bquo vadis? /$cedited by J.L. Gordon.
260 $aBasel ;$aBoston :$bBirkhäuser Verlag,$c1984.
300 $aviii, 312 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aAgents and actions supplements ;$vv. 15
500 $a"Communications from a symposium on ticlopidine, held at the Centre de Recherches Clin-Midy in Montpellier on the 20/21st October 1983"--Pref.
504 $aIncludes bibliographies and index.
650 0 $aThrombolytic therapy$vCongresses.
650 0 $aTiclopidine$xTesting$vCongresses.
650 0 $aBlood platelets$xEffect of drugs on$vCongresses.
650 0 $aThrombosis$xPrevention$vCongresses.
650 2 $aAnticoagulants.$0https://id.nlm.nih.gov/mesh/D000925
650 2 $aThiophenes$xpharmacology.$0https://id.nlm.nih.gov/mesh/D013876Q000494
650 2 $aThiophenes$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D013876Q000627
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aGordon, J. L.$0http://id.loc.gov/authorities/names/n81035369
830 0 $aAgents and actions supplements ;$vAAS 15.$0http://id.loc.gov/authorities/names/n42001287
852 00 $boff,hsl$hRC694.3$iT43 1984